Literature DB >> 8824968

Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey.

J P Bédos1, S Chevret, C Chastang, P Geslin, B Régnier.   

Abstract

A nationwide retrospective study was performed in France to describe the susceptibility of Streptococcus pneumoniae strains to penicillin G and to identify risk factors for infection with nonsusceptible strains. From January 1991 to May 1992, 10,350 S. pneumoniae strains were recorded. The overall rate of penicillin-nonsusceptible pneumococcal (PNSP) strains was 11%; specific prevalence rates, according to the sources of the isolates, were as follows: blood, 6%; cerebrospinal fluid, 10%; lower respiratory tract, 10%; and middle ear, 18%. Large variations in regional distribution were observed. In 85% of cases, PNSP strains belonged to serogroup 23, 19, 6, 14, or 9, by order of decreasing frequency. A logistic regression model identified the following factors as being associated with PNSP infections: age of < 15 years (OR = 2.01), isolation of the organisms from the upper respiratory tract (OR = 2.36) or from sinus and middle ear (OR = 1.63), HIV infection (OR = 2.01), beta-lactam antimicrobial therapy in the previous 6 months (OR = 1.99), and nosocomial acquisition (OR = 2.12). The attributable risk of beta-lactam antimicrobial therapy in the previous 6 months was 19%, showing that suppression of this factor alone could not eradicate PNSP infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824968     DOI: 10.1093/clinids/22.1.63

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities.

Authors:  M Benbachir; S Benredjeb; C S Boye; M Dosso; H Belabbes; A Kamoun; O Kaire; N Elmdaghri
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.

Authors:  Jean-Winoc Decousser; Patrick Pina; Florent Viguier; Franc Picot; Patrice Courvalin; Pierre Allouch
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.

Authors:  D Scheifele; S Halperin; L Pelletier; J Talbot; M Lovgren; W Vaudry; T Jadavji; B Law; N Macdonald; R Gold; E Wang; E Mills; M Lebel; P Déry; R Morris
Journal:  Can J Infect Dis       Date:  2001-07

5.  Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.

Authors:  P A Frick; D J Black; J S Duchin; S Deliganis; W M McKee; T R Fritsche
Journal:  West J Med       Date:  1998-12

Review 6.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 7.  Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).

Authors:  A Fenoll; I Jado; D Vicioso; A Pérez; J Casal
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

8.  High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

Authors:  R L Moolenaar; R Pasley-Shaw; J R Harkess; A Lee; J M Crutcher
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

9.  Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep.

Authors:  John Quale; David Landman; Jayashree Ravishankar; Carlos Flores; Simona Bratu
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

Review 10.  Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams.

Authors:  Claude Carbon; Raul Isturiz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.